458 related articles for article (PubMed ID: 28062854)
1. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
[TBL] [Abstract][Full Text] [Related]
2. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of Hsh155/SF3b1 interactions with the U2 snRNA/branch site duplex.
Carrocci TJ; Paulson JC; Hoskins AA
RNA; 2018 Aug; 24(8):1028-1040. PubMed ID: 29752352
[TBL] [Abstract][Full Text] [Related]
4. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
[TBL] [Abstract][Full Text] [Related]
5. Evidence for complex dynamics during U2 snRNP selection of the intron branchpoint.
Kao CY; Cao EC; Wai HL; Cheng SC
Nucleic Acids Res; 2021 Sep; 49(17):9965-9977. PubMed ID: 34387687
[TBL] [Abstract][Full Text] [Related]
6. Cus2 enforces the first ATP-dependent step of splicing by binding to yeast SF3b1 through a UHM-ULM interaction.
Talkish J; Igel H; Hunter O; Horner SW; Jeffery NN; Leach JR; Jenkins JL; Kielkopf CL; Ares M
RNA; 2019 Aug; 25(8):1020-1037. PubMed ID: 31110137
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into how Prp5 proofreads the pre-mRNA branch site.
Zhang Z; Rigo N; Dybkov O; Fourmann JB; Will CL; Kumar V; Urlaub H; Stark H; Lührmann R
Nature; 2021 Aug; 596(7871):296-300. PubMed ID: 34349264
[TBL] [Abstract][Full Text] [Related]
8. Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1.
Zhang J; Ali AM; Lieu YK; Liu Z; Gao J; Rabadan R; Raza A; Mukherjee S; Manley JL
Mol Cell; 2019 Oct; 76(1):82-95.e7. PubMed ID: 31474574
[TBL] [Abstract][Full Text] [Related]
9. Disclosing the Impact of Carcinogenic SF3b Mutations on Pre-mRNA Recognition Via All-Atom Simulations.
Borišek J; Saltalamacchia A; Gallì A; Palermo G; Molteni E; Malcovati L; Magistrato A
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31640290
[TBL] [Abstract][Full Text] [Related]
10. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.
Jenkins JL; Kielkopf CL
Trends Genet; 2017 May; 33(5):336-348. PubMed ID: 28372848
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of the DEAD-box ATPase Prp5 RecA-like domains provide a conformational switch during spliceosome assembly.
Beier DH; Carrocci TJ; van der Feltz C; Tretbar US; Paulson JC; Grabowski N; Hoskins AA
Nucleic Acids Res; 2019 Nov; 47(20):10842-10851. PubMed ID: 31712821
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP
Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for recognition of intron branchpoint RNA by yeast Msl5 and selective effects of interfacial mutations on splicing of yeast pre-mRNAs.
Jacewicz A; Chico L; Smith P; Schwer B; Shuman S
RNA; 2015 Mar; 21(3):401-14. PubMed ID: 25587180
[TBL] [Abstract][Full Text] [Related]
16. Structures of SF3b1 reveal a dynamic Achilles heel of spliceosome assembly: Implications for cancer-associated abnormalities and drug discovery.
Maji D; Grossfield A; Kielkopf CL
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194440. PubMed ID: 31707043
[TBL] [Abstract][Full Text] [Related]
17. DExD/H-box Prp5 protein is in the spliceosome during most of the splicing cycle.
Kosowski TR; Keys HR; Quan TK; Ruby SW
RNA; 2009 Jul; 15(7):1345-62. PubMed ID: 19451545
[TBL] [Abstract][Full Text] [Related]
18. Molecular architecture of the human 17S U2 snRNP.
Zhang Z; Will CL; Bertram K; Dybkov O; Hartmuth K; Agafonov DE; Hofele R; Urlaub H; Kastner B; Lührmann R; Stark H
Nature; 2020 Jul; 583(7815):310-313. PubMed ID: 32494006
[TBL] [Abstract][Full Text] [Related]
19. SF3B1 mutant myelodysplastic syndrome: Recent advances.
Pellagatti A; Boultwood J
Adv Biol Regul; 2021 Jan; 79():100776. PubMed ID: 33358369
[TBL] [Abstract][Full Text] [Related]
20. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms.
Brierley CK; Steensma DP
Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
